Rosanne M. Orr

Induction of apoptosis by a novel copper-based anticancer compound, Casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cells

Andrea De Vizcaya‐Ruíz, Adolfo Rivero‐Müller, George E.N. Kass et al. · Toxicology in Vitro · 2000 · 133 citations

L1210 Murine Leukaemia, Medicine, Apoptosis +10

Pharmacokinetics of G3139, a Phosphorothioate Oligodeoxynucleotide Antisense to bcl-2, after Intravenous Administration or Continuous Subcutaneous Infusion to Mice

Florence I. Raynaud, Rosanne M. Orr, Phyllis M. Goddard et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 107 citations

Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.

Rosanne M. Orr · PubMed · 2001 · 89 citations

Technology Evaluation, Pharmaceutical Research, Immunotherapy +13

Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival.

Jane Renshaw, Rosanne M. Orr, Michael I. Walton et al. · PubMed · 2004 · 32 citations

Transcriptional Regulation, Radiation Oncology, Systems Biology +14

Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.

Phyllis M. Goddard, Rosanne M. Orr, Melanie Valenti et al. · PubMed · 1996 · 32 citations

Cisplatin Resistance, Nanomedicine, Tumor Biology +15